null

Enapotamab (Anti-AXL) Biosimilar Antibody

SKU:
HDBS0033
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
AXL
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-AXL enapotamab biosimilar mAb HDBS0033
  • Anti-AXL enapotamab biosimilar mAb HDBS0033
  • Anti-AXL enapotamab biosimilar mAb HDBS0033
€373
Frequently bought together:

Description

system_update_altDatasheet

Enapotamab (Anti-AXL) Biosimilar Antibody (HDBS0033)

The Anti-AXL Enapotamab Biosimilar MAb (HDBS0033) is a monoclonal antibody designed for research involving AXL, a cell surface receptor known for its role in promoting cell survival, proliferation, and migration in cancer cells. This biosimilar monoclonal antibody, derived from a humanized mouse, exhibits high specificity and affinity for AXL and is validated for use in various immunoassays, including flow cytometry and immunohistochemistry.AXL, a member of the TAM (TYRO3, AXL, MER) family of receptor tyrosine kinases, is a promising target for cancer therapy due to its involvement in promoting tumor growth, metastasis, and resistance to chemotherapy.

The Anti-AXL Enapotamab Biosimilar MAb (HDBS0033) offers researchers a reliable tool for studying AXL-mediated signaling pathways and exploring novel approaches for targeted cancer treatment.By interrogating the interaction between AXL and its ligand, Gas6, researchers can gain insights into the mechanisms driving tumor progression and identify potential strategies for inhibiting AXL signaling in various cancer types. The Anti-AXL Enapotamab Biosimilar MAb (HDBS0033) is a valuable resource for advancing our understanding of AXL biology and developing innovative therapeutic interventions for cancer patients.